Ian Clark

(Mr. Ian Clark Ph.D.)

Currently holds positions in Genentech Inc, TerraVia Holdings Inc, Agios Pharmaceuticals Inc, Kite Pharma Inc, AVROBIO Inc and Guardant Health Inc

Positions
Position Company Period
Executive Vice President - Commercial Operations Genentech Inc Dec. 1, 2005 -
Independent Director TerraVia Holdings Inc April 1, 2011 -
Independent Director Agios Pharmaceuticals Inc Dec. 30, 2016 -
Independent Director Kite Pharma Inc Jan. 3, 2017 -
Independent Director AVROBIO Inc Jan. 1, 2018 -
Lead Independent Director Guardant Health Inc Dec. 31, 2016 -
Independent Director Forty Seven Inc April 1, 2018 - April 7, 2020
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2021-04-28 2021-04-26
PS Planned sale
538 -10.4%
159.92
86,037 USD
538 -10.4% 159.92 86,037 USD
2021-03-29 2021-03-25
PS Planned sale
538 -10.4%
132.09
71,064 USD
538 -10.4% 132.09 71,064 USD
2021-03-01 2021-02-25
PS Planned sale
538 -10.4%
154.00
82,852 USD
538 -10.4% 154.00 82,852 USD
2021-01-27 2021-01-25
PS Planned sale
538 -10.4%
162.00
87,156 USD
538 -10.4% 162.00 87,156 USD
2021-01-06 2021-01-04
PS Planned sale
2,690 -36.7%
129.23
347,629 USD
2,690 -36.7% 129.23 347,629 USD
2020-12-30 2020-12-28
PS Planned sale
538 -10.4%
135.00
72,630 USD
538 -10.4% 135.00 72,630 USD
2020-12-07 2020-12-03
PS Planned sale
2,690 -36.7%
120.00
322,800 USD
2,690 -36.7% 120.00 322,800 USD
2020-11-27 2020-11-25
PS Planned sale
538 -10.4%
113.28
60,945 USD
538 -10.4% 113.28 60,945 USD
2020-11-05 2020-11-03
PS Planned sale
2,690 -36.7%
105.28
283,203 USD
2,690 -36.7% 105.28 283,203 USD
2020-10-28 2020-10-26
PS Planned sale
538 -10.4%
104.03
55,968 USD
538 -10.4% 104.03 55,968 USD
2020-10-05 2020-10-05
PS Planned sale
2,690 -36.7%
108.50
291,865 USD
2,690 -36.7% 108.50 291,865 USD
2020-10-05 2020-09-25
PS Planned sale
538 -10.4%
106.24
57,157 USD
538 -10.4% 106.24 57,157 USD
2020-09-10 2020-09-08
PS Planned sale
1,136 -19.7%
90.54
102,853 USD
1,136 -19.7% 90.54 102,853 USD
2020-09-10 2020-09-08
PS Planned sale
2,747 -32.2%
89.78
246,612 USD
2,747 -32.2% 89.78 246,612 USD
2020-09-10 2020-09-08
PS Planned sale
5,263 -38.2%
88.69
466,782 USD
5,263 -38.2% 88.69 466,782 USD
2020-06-05 2020-06-03
PS Planned sale
2,690 -67.4%
87.52
235,429 USD
2,690 -67.4% 87.52 235,429 USD
2020-05-26 2020-05-26
PS Planned sale
538 -29.2%
98.50
52,993 USD
538 -29.2% 98.50 52,993 USD
2020-05-06 2020-05-04
PS Planned sale
2,690 -67.4%
72.17
194,137 USD
2,690 -67.4% 72.17 194,137 USD
2020-04-29 2020-04-27
PS Planned sale
538 -29.2%
77.50
41,695 USD
538 -29.2% 77.50 41,695 USD
2020-04-16 2020-04-14
PS Planned sale
2,689 -67.4%
70.00
188,230 USD
2,689 -67.4% 70.00 188,230 USD
2020-03-27 2020-03-25
PS Planned sale
538 -29.2%
70.00
37,660 USD
538 -29.2% 70.00 37,660 USD
2020-03-04 2020-03-03
PS Planned sale
2,690 -67.4%
78.33
210,708 USD
2,690 -67.4% 78.33 210,708 USD
2020-02-27 2020-02-25
PS Planned sale
538 -29.2%
80.00
43,040 USD
538 -29.2% 80.00 43,040 USD
2020-02-05 2020-02-03
PS Planned sale
2,690 -67.4%
76.23
205,059 USD
2,690 -67.4% 76.23 205,059 USD
2020-01-29 2020-01-27
PS Planned sale
538 -29.2%
77.31
41,593 USD
538 -29.2% 77.31 41,593 USD
2020-01-07 2020-01-03
PS Planned sale
2,690 -67.4%
77.87
209,470 USD
2,690 -67.4% 77.87 209,470 USD
2019-11-27 2019-11-25
PS Planned sale
538 -29.2%
78.17
42,055 USD
538 -29.2% 78.17 42,055 USD
2019-10-29 2019-10-28
PS Planned sale
3,228 -71.3%
70.00
225,960 USD
3,228 -71.3% 70.00 225,960 USD
2019-09-27 2019-09-25
PS Planned sale
538 -29.2%
72.00
38,736 USD
538 -29.2% 72.00 38,736 USD
2019-09-05 2019-09-03
PS Planned sale
2,690 -67.4%
85.70
230,533 USD
2,690 -67.4% 85.70 230,533 USD
2019-05-03 2019-05-03
PS Planned sale
2,690 -100.0%
65.91
177,298 USD
2,690 -100.0% 65.91 177,298 USD
2019-04-29 2019-04-25
PS Planned sale
538 -100.0%
65.11
35,029 USD
538 -100.0% 65.11 35,029 USD
2019-04-17 2019-04-15
PS Planned sale
81,772 -100.0%
73.90
6,042,951 USD
81,772 -100.0% 73.90 6,042,951 USD